SCHEMBL303253

SCHEMBL303253

O=C1CC(S(=O)(=O)O)C(=O)N1O.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186069 1.00
SCHEMBL1012068 0.98
SCHEMBL19207 0.98
SCHEMBL3623489 0.98
SCHEMBL1867164 0.98
Water SCHEMBL3416842 0.96
SCHEMBL14763449 0.96
SCHEMBL31474323 0.96 MMP1 (0.30)
Phosphine SCHEMBL19611318 0.96
Hydrochloric Acid SCHEMBL31598675 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1087 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080614-A PEG/PEI nanocomposite based on carboxymethyl cellulose and preparation method and application thereof 2026-05-26 CN claimed
CN-118307789-A Resin microsphere for blood perfusion and preparation method and application thereof 河南驼人医疗器械研究院有限公司 2024-07-09 CN claimed
CN-115011563-B Preparation method of aminated gold nanoparticle-phage T156 recognition probe and kit thereof 华中农业大学 2024-07-02 CN claimed
US-20240156854-A1 METHYLCOBALAMIN OPHTHALMIC PREPARATION AND USE THEREOF EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITY (CN) 2024-05-16 US claimed
CN-116327802-B Sipunculus nudus polypeptide functionalized iridium oxide nano-enzyme with antibacterial effect and preparation method and application thereof 广东医科大学 2024-03-26 CN claimed
CN-116990499-B MBs-ssDNA-hCG probe, kit and application thereof in detection of IAP 西安交通大学 2024-03-01 CN claimed
CN-117517665-A Kit for determining anti-sperm antibody IgG and application thereof 四川沃文特生物技术有限公司 2024-02-06 CN claimed
CN-116023557-B Preparation method and application of CBM modified amphoteric polyacrylamide 南京林业大学 2024-01-30 CN claimed
CN-117384465-A Nano-diamond based antibacterial wear-resistant material and preparation method thereof 郑州大学 2024-01-12 CN claimed
CN-117362665-A Chiral MOFs material and application thereof in resolution of chiral medicine amlodipine 武汉理工大学 2024-01-09 CN claimed
US-20050074411-A1 Peptide-based multimeric targeted contrast agents EPIX MEDICAL, INC. A DELAWARE CORPORATION 2005-04-07 US claimed
CN-1599577-A Peptide-based multimeric targeted contrast media EPIX MEDICAL INC (US) 2005-03-23 CN claimed
EP-1504064-A1 PROCESS FOR PREPARING MODIFIED PIGMENTS CABOT CORPORATION (US) 2005-02-09 EP claimed
EP-1420681-A2 PEPTIDE-BASED MULTIMERIC TARGETED CONTRAST AGENTS Epix Medical, Inc. (US) 2004-05-26 EP claimed
US-6699319-B2 Reacting a pigment having a nucleophilic group (e.g., a diazonium or amine group) with a polymer containing carboxylic acid groups or salts and a coupler CABOT CORPORATION 2004-03-02 US claimed
US-20030213410-A1 Combining, a pigment having attached at least one nucleophilic group, at least one polymer containing a carboxylic acid group or salt and a coupling agent CABOT CORPORATION 2003-11-20 US claimed
WO-2003095565-A1 PROCESS FOR PREPARING MODIFIED PIGMENTS CABOT CORPORATION (US) 2003-11-20 WO claimed
US-20030205171-A1 Reacting a pigment having a nucleophilic group (e.g., a diazonium or amine group) with a polymer containing carboxylic acid groups or salts and a coupler CABOT CORPORATION 2003-11-06 US claimed
US-20030180222-A1 Peptide-based multimeric targeted contrast agents EPIX PHARMACEUTICALS, INC. 2003-09-25 US claimed
WO-2003011115-A2 PEPTIDE-BASED MULTIMERIC TARGETED CONTRAST AGENTS EPIX MEDICAL, INC. (US) 2003-02-13 WO claimed